PLSE
Pulse BiosciencesCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
Current thesis
The best post-print argument is that PLSE improved the pacing of its core AF program: management now expects NANOPULSE-AF enrollment completion in early Q4 2026, and the accompanying clinical update continued to show high procedural success and durability in feasibility patients [#PR-2026-05-04]. If execution holds, the stock can continue to trade on EP platform optionality rather than current revenue.
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -3.5.
What can break
Cash burn remains meaningful: Q1 2026 operating cash use was $14.6 million and quarter-end cash was $68.3 million, versus $80.7 million at year-end 2025 [#PR-2026-05-04].
Momentum
86
Value
36
Sentiment
32
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.00 · Bull $28.00 · Bear $13.00
Data freshness
Prices
As of 2026-06-18
Fundamentals
As of 2026-06-15 • Vendor: Data Vendor v1
Scores
As of 2026-06-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-18
Investment thesis
As of 2026-06-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $30.00
Why
Momentum86 · Δ7d -3.5
Value36 · Δ7d +0.0
Sentiment32 · Δ7d +3.8
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
86
34% active weight
Current posture
7d trendSoftening
Δ7d
-3.5
Δ21d
-0.5
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
32
33% active weight
Current posture
7d trendImproving
Δ7d
+3.8
Δ21d
-2.9
Why this grade
Composite grade C. Momentum 85.5 / Value 36.3 / Sentiment 32.1
Fundamentals (TTM)As of 2026-06-15
Fundamentals (TTM)
As of 2026-06-15
Market Cap
$1.79B
Beta
1.77
Shares Out
67.77M
P/E (TTM) · Derived
-24.5
P/S (TTM)
11504.73
P/FCF (TTM) · Derived
-35.79
Rev YoY
-
EPS YoY
-38.5%
Gross Margin
-224.4%
Op Margin
-91798.8%
Net Debt
-$118.04M
Current Ratio
10.02
As of 2026-06-18 • Updated nightlySource: Internal modelMethodology

